Tower Research Capital LLC (Trc) Intercept Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$9.99 - $18.71 $110,289 - $206,558	-11,040 Reduced 86.85%	1,672 $30,000
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $25,116 - $52,835	2,739 Added 27.46%	12,712 $140,000
Q1 2023 May 09, 2023	BUY	$12.53 - $21.71 $1,215 - $2,105	97 Added 0.98%	9,973 $134,000
Q4 2022 Feb 10, 2023	SELL	$11.61 - $16.11 $319,228 - $442,960	-27,496 Reduced 73.57%	9,876 $122,000
Q3 2022 Nov 10, 2022	BUY	$12.21 - $19.7 $353,516 - $570,374	28,953 Added 343.9%	37,372 $521,000
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $50,052 - $87,312	4,457 Added 112.49%	8,419 $116,000
Q1 2022 May 12, 2022	SELL	$13.37 - $17.79 $47,811 - $63,617	-3,576 Reduced 47.44%	3,962 $64,000
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $121,879 - $166,688	-8,535 Reduced 53.1%	7,538 $123,000
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $173,559 - $273,499	13,361 Added 492.66%	16,073 $239,000
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $7,127 - $11,294	461 Added 20.48%	2,712 $54,000
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $146,154 - $285,427	-7,561 Reduced 77.06%	2,251 $52,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $190,797 - $331,011	7,794 Added 386.22%	9,812 $242,000
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $75,756 - $103,566	-1,938 Reduced 48.99%	2,018 $84,000
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $184,745 - $364,110	3,956 New	3,956 $189,000
Q4 2019 Feb 07, 2020	SELL	$57.36 - $124.1 $31,548 - $68,255	-550 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$58.69 - $80.46 $32,279 - $44,253	550 New	550 $36,000
Q2 2019 Aug 13, 2019	SELL	$77.77 - $120.68 $12,598 - $19,550	-162 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$91.83 - $120.68 $8,907 - $11,705	-97 Reduced 37.45%	162 $18,000
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $13,726 - $20,233	160 Added 161.62%	259 $26,000
Q3 2018 Nov 13, 2018	BUY	$88.49 - $127.55 $8,760 - $12,627	99 New	99 $13,000
Q2 2018 Aug 15, 2018	SELL	$60.0 - $85.67 $114,960 - $164,143	-1,916 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $46,393 - $59,180	880 Added 84.94%	1,916 $118,000
Q4 2017 Feb 09, 2018	BUY	$58.2 - $72.76 $15,015 - $18,772	258 Added 33.16%	1,036 $61,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $44,353 - $92,387	778	778 $45,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account